We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $53.5M
1-Year Est. Return 80.67%
This Fund
S&P 500
This Quarter Est. Return
+13.01%
1 Year Est. Return
+80.67%
3 Year Est. Return
+80.2%
5 Year Est. Return
+49.87%
10 Year Est. Return
+446.13%
AUM
$46.3M
AUM Growth
-$7.06M
Cap. Flow
-$13.8M
Cap. Flow %
-29.76%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
EGHT icon
8x8 Inc
EGHT
+$553

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$11.9M
2
SANA icon
Sana Biotechnology
SANA
+$1.83M

Sector Composition

Rank Sector Weight
1 Healthcare 96.44%
2 Technology 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNLI icon
1
Denali Therapeutics
DNLI
$3.94B
$42.4M 91.74%
2,210,732
-600,000
-21% -$11.9M
SANA icon
2
Sana Biotechnology
SANA
$1.22B
$2.18M 4.7%
755,736
-465,201
-38% -$1.83M
EGHT icon
3
8x8 Inc
EGHT
$290M
$1.64M 3.56%
990,850
+270
+0% +$553

Similar funds

OM
OV Management Minneapolis, Minnesota $53.5M AUM 5.46% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $53.5M AUM 26.99% 1-Year Est. Return
HCM
Harspring Capital Management New York $53.7M AUM 23.29% 1-Year Est. Return
ETCM
Evolutionary Tree Capital Management Alexandria, Virginia $53M AUM 24.7% 1-Year Est. Return
IDBONY
Israel Discount Bank of New York New York $54M AUM 13.02% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $52.9M AUM 2.04% 1-Year Est. Return
TCDRS
Texas County & District Retirement System Austin, Texas $54.6M AUM 22.55% 1-Year Est. Return
FPAM
Feynman Point Asset Management New York $54.7M AUM

Crestline Management's Q1 2026 Portfolio in Review

As of Q1 2026, Crestline Management held 3 positions worth $46.3M, down 13% from $53.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Crestline Management withdrew a net $13.8M in Q1 2026, reducing 2 holdings. Its largest reduction was Denali Therapeutics, cutting an estimated $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Technology.

Against the trend, Crestline Management added an estimated $553 to 8x8 Inc.

  • Crestline Management added most to 8x8 Inc in Q1 2026, an estimated $553 increase.
  • Crestline Management's biggest Q1 2026 reduction was Denali Therapeutics, cutting an estimated $11.9M.
  • Crestline Management's ten largest holdings make up 100% of its $46.3M portfolio in Q1 2026.
  • Crestline Management opened 0 new positions and closed 0 in Q1 2026.
  • Crestline Management's portfolio value fell 13% quarter-over-quarter to $46.3M.

Based on Crestline Management's 13F filing for Q1 2026, filed 15 May 2026.